Stories, perspectives and news coverage of Prime Therapeutics/Magellan Rx from AMCP 2024

Prime Therapeutics researchers share how the model helps to optimize drug therapy and lower costs

Prime Therapeutics offers innovative medication management solutions, supports patients with chronic conditions

Abby Kim, PharmD, BCOP, senior director of oncology, clinical strategy and specialty solutions at Prime Therapeutics, examines the trends payers should watch as cancer care becomes more complex

Abby Kim, PharmD, BCOP, is a senior director, clinical strategy and oncology specialty solutions, shares key takeaways from the American Journal of Managed Care (AJMC) forum, “Bridging evidence and...

Pat Gleason, assistant vice president, health outcomes, and David Eckwright, senior director, clinical project and program management, share an overview of Prime’s data and insights slated for this...

Prime simplifies the cancer care pathway through innovative solutions that help manage complex conditions

In the latest episode of the “Pharmacy Friends” podcast, hear more about what faster drug decisions could mean for evidence review, affordability assessment and implementation planning

From new treatment options for dry eye disease to type 2 diabetes, here are a few of the top U.S. Food and Drug Administration drug decisions expected this year

Prime works to simplify medication management and support patients with migraine, making migraine treatment less of a pain point